PMN
Income statement / Annual
Last year (2025), ProMIS Neurosciences Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, ProMIS Neurosciences Inc.'s net income was -$39.72 M.
See ProMIS Neurosciences Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$8.14 K |
$1.57 K |
$1.20 K |
$348.74 |
$7.87 K |
$2.00 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$10.44 M
|
$15.07 K
|
$5.85 M
|
$3.18 M
|
$4.74 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
-$10.44 M
|
-$15.07 K
|
-$5.84 M
|
-$3.18 M
|
-$4.73 M
|
$348.74
|
$7.87 K
|
$2.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
-718.03
|
-2032.96
|
-3938.53
|
1
|
1
|
1
|
| Research and Development Expenses |
$33.38 M
|
$10.64 M
|
$7.88 M
|
$21.62 M
|
$4.95 M
|
$3.18 M
|
$4.74 M
|
$5.44 M
|
$3.15 M
|
$1.39 M
|
| General & Administrative Expenses |
$6.79 M
|
$6.19 M
|
$7.39 M
|
$9.80 M
|
$3.31 M
|
$2.44 M
|
$2.62 M
|
$2.02 M
|
$1.64 M
|
$1.17 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
-$1.01 M
|
$0.00
|
$0.00
|
$36.48 K
|
$43.89 K
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.79 M
|
$6.19 M
|
$6.38 M
|
$9.80 M
|
$3.31 M
|
$2.48 M
|
$2.66 M
|
$2.02 M
|
$1.64 M
|
$1.17 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$5.81 M
|
$0.00
|
-$3.63 M
|
-$3.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$40.17 M
|
$16.83 M
|
$8.45 M
|
$31.41 M
|
$4.63 M
|
$2.48 M
|
$7.40 M
|
$7.46 M
|
$4.79 M
|
$2.56 M
|
| Cost And Expenses |
$40.17 M
|
$16.83 M
|
$18.90 M
|
$31.41 M
|
$10.48 M
|
$5.66 M
|
$12.13 M
|
$7.46 M
|
$4.79 M
|
$2.56 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.73 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$76.78 K
|
$201.39 K
|
$378.99 K
|
$416.29 K
|
$0.00
|
$0.00
|
$0.00
|
$5.65 K
|
$15.89 K
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$28.04 K
|
$15.07 K
|
$45.83 K
|
$15.73 K
|
$8.56 K
|
$4.90 K
|
$5.31 K
|
$4.96 K
|
| EBITDA |
-$39.72 M |
$2.86 M |
-$17.81 M |
-$23.88 M |
-$9.33 M |
-$5.65 M |
-$7.39 M |
-$7.46 M |
-$4.78 M |
-$2.55 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
-1146.23
|
-3608.23
|
-6146.17
|
-21390.27
|
-607.05
|
-1275.57
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
-1013.72
|
-3618.14
|
-10092.83
|
-21404.32
|
-607.73
|
-1278.05
|
| Total Other Income/Expenses Net |
$448.16 K
|
$19.61 M
|
$1.39 M
|
$7.15 M
|
-$1.50 M
|
$0.00
|
$4.74 M
|
$0.00
|
-$5.65 K
|
-$11.82 K
|
| Income Before Tax |
-$39.72 M
|
$2.78 M
|
-$17.51 M
|
-$24.27 M
|
-$9.79 M
|
-$5.66 M
|
-$7.40 M
|
-$7.46 M
|
-$5.90 M
|
-$2.57 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
-1203.01
|
-3618.14
|
-6153.29
|
-21404.32
|
-749.36
|
-1283.95
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$5.65 K
|
$11.82 K
|
| Net Income |
-$39.72 M
|
$2.78 M
|
-$17.51 M
|
-$24.27 M
|
-$11.98 M
|
-$5.66 M
|
-$7.40 M
|
-$7.46 M
|
-$4.79 M
|
-$2.57 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
-1472.04
|
-3618.14
|
-6153.29
|
-21404.32
|
-608.45
|
-1283.95
|
| EPS |
-22.61 |
2.75 |
-35.5 |
-80.9 |
-51.77 |
-28.32 |
-42.87 |
-46.75 |
-35 |
-22.75 |
| EPS Diluted |
-22.61 |
2.75 |
-35.5 |
-80.9 |
-51.77 |
-28.32 |
-42.87 |
-46.75 |
-35 |
-22.75 |
| Weighted Average Shares Out |
$1.76 B
|
$1.04 M
|
$491.71 K
|
$300.10 K
|
$231.42 K
|
$190.40 K
|
$173.20 K
|
$159.46 K
|
$137.19 K
|
$113.26 K
|
| Weighted Average Shares Out Diluted |
$1.76 B
|
$1.06 M
|
$491.71 K
|
$300.10 K
|
$231.43 K
|
$190.40 K
|
$173.20 K
|
$159.46 K
|
$137.19 K
|
$113.26 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
